Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study
While the risk of SJS/TEN is higher among patients treated with ICIs compared to those receiving other types of antineoplastic agents, the overall incidence in the real-world setting remains low.
Authors
- R H Olsen (ORCID: https://orcid.org/0000-0001-8114-365X)
- Christian Kjer Heerfordt (ORCID: https://orcid.org/0000-0001-8485-3235)
- Henrik Horwitz (ORCID: https://orcid.org/0000-0001-6436-1567)
- Ida M. Heerfordt (ORCID: https://orcid.org/0000-0002-6130-875X)
- Magnus Middelboe
Institutions
- University of Copenhagen (DK)
- Frederiksberg Hospital (DK)
- Copenhagen University Hospital (DK)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/pds.70272
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00